Online citations, reference lists, and bibliographies.
← Back to Search

Synthetic (E)-3-Phenyl-5-(phenylamino)-2-styryl-1,3,4-thiadiazol-3-ium Chloride Derivatives As Promising Chemotherapy Agents On Cell Lines Infected With HTLV-1

Danilo Sousa-Pereira, Thais Silva de Oliveira, R. O. Paiva, O. Chaves, J. C. Netto-Ferreira, J. Echevarria-Lima, Á. Echevarria
Published 2020 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Synthesis of four compounds belonging to mesoionic class, (E)-3-phenyl-5-(phenylamino)-2-styryl-1,3,4-thiadiazol-3-ium chloride derivatives (5a–d) and their biological evaluation against MT2 and C92 cell lines infected with human T-cell lymphotropic virus type-1 (HTLV-1), which causes adult T-cell leukemia/lymphoma (ATLL), and non-infected cell lines (Jurkat) are reported. The compounds were obtained by convergent synthesis under microwave irradiation and the cytotoxicity was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Results showed IC50 values of all compounds in the range of 1.51–7.70 μM in HTLV-1-infected and non-infected cells. Furthermore, it was observed that 5b could induce necrosis after 24 h for Jurkat and MT2 cell lines. The experimental (fluorimetric method) and theoretical (molecular docking) results suggested that the mechanism of action for 5b could be related to its capacity to intercalate into DNA. Moreover, the preliminary pharmacokinetic profile of the studied compounds (5a–d) was obtained through human serum albumin (HSA) binding affinity using multiple spectroscopic techniques (circular dichroism, steady-state and time-resolved fluorescence), zeta potential and molecular docking calculations. The interaction HSA:5a–d is spontaneous and moderate (Ka ~ 104 M−1) via a ground-state association, without significantly perturbing both the secondary and surface structures of the albumin in the subdomain IIA (site I), indicating feasible biodistribution in the human bloodstream.
This paper references
10.1016/J.JPHOTOCHEMREV.2012.09.001
Binding of serum albumins with bioactive substances – Nanoparticles to drugs
S. Naveenraj (2013)
10.1007/s12325-018-0658-4
A Review of New Findings in Adult T-cell Leukemia–Lymphoma: A Focus on Current and Emerging Treatment Strategies
O. Hermine (2018)
10.1186/s12866-015-0340-9
Mesoionic compounds with antifungal activity against Fusarium verticillioides
R. O. Paiva (2015)
10.1093/jac/dkr409
The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
R. Rodrigues (2012)
10.1039/C6PP00209A
In situ ultra-fast heat deposition does not perturb the structure of serum albumin.
O. Chaves (2016)
10.3322/caac.21492
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
F. Bray (2018)
10.1016/j.cbi.2010.09.030
Interaction of 1,3,4-thiadiazolium mesoionic derivatives with mitochondrial membrane and scavenging activity: Involvement of their effects on mitochondrial energy-linked functions.
Amanda R A Pires (2011)
10.1590/S0103-50532011000800014
Improved synthesis of 1,3,4-thiadiazolium-2-phenylamines using microwave and ultrasound irradiation and investigation of their cytotoxic activity
C. M. Reis (2011)
10.1016/j.bioorg.2018.07.035
Synthesis and biological evaluation of N-aryl-2-phenyl-hydrazinecarbothioamides: Experimental and theoretical analysis on tyrosinase inhibition and interaction with HSA.
Danilo Sousa-Pereira (2018)
10.1016/S0140-6736(85)92734-5
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
A. Gessain (1985)
10.1016/j.jpba.2009.09.037
Interaction of kaempferol with human serum albumin: a fluorescence and circular dichroism study.
I. Matei (2010)
10.1016/j.jphotobiol.2016.12.007
Anti-inflammatory, analgesic and COX-2 inhibitory activity of novel thiadiazoles in irradiated rats.
F. A. Ragab (2017)
10.1097/00001813-200403000-00012
Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure–activity relationship study
A. Senff-Ribeiro (2004)
10.1073/PNAS.78.4.2179
Structure of a B-DNA dodecamer: conformation and dynamics.
H. Drew (1981)
10.1006/BBRC.2002.6540
The atomic structure of human methemalbumin at 1.9 A.
M. Wardell (2002)
10.1016/j.molstruc.2019.127147
Multi-spectroscopic and molecular docking technique study of the azelastine interaction with human serum albumin
Fahad M. Almutairi (2020)
10.3390/biom8030078
Multi-Spectroscopic and Theoretical Analysis on the Interaction between Human Serum Albumin and a Capsaicin Derivative—RPF101
O. Chaves (2018)
10.3389/fmicb.2018.00925
Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma
Francesca Marino-Merlo (2018)
10.1371/journal.pone.0130046
Selective Cytotoxicity of 1,3,4-Thiadiazolium Mesoionic Derivatives on Hepatocarcinoma Cells (HepG2)
G. Gozzi (2015)
10.1111/j.1365-2141.1991.tb08051.x
Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma
M. Shimoyama (1991)
10.1016/j.ijbiomac.2018.02.050
Novel piperonal 1,3,4-thiadiazolium-2-phenylamines mesoionic derivatives: Synthesis, tyrosinase inhibition evaluation and HSA binding study.
Natália Drumond Lopes (2018)
10.1038/sj.bjc.6605345
Mechanisms of HTLV-1 persistence and transformation
M. Boxus (2009)
10.1021/JM00119A008
Synthesis and antileukemic activity of bis[[(carbamoyl)oxy]methyl]- substituted pyrrolo[2,1-a]isoquinolines, pyrrolo[1,2-a]quinolines, pyrrolo[2,1-a]isobenzazepines, and pyrrolo[1,2-a]benzazepines.
W. A. Anderson (1988)
10.1016/J.MOLLIQ.2018.01.083
Synthesis, tyrosinase inhibition and transportation behavior of novel β-enamino thiosemicarbazide derivatives by human serum albumin
O. Chaves (2018)
10.1016/j.bmc.2007.12.049
Novel 1,3,4-thiadiazolium-2-phenylamine chlorides derived from natural piperine as trypanocidal agents: chemical and biological studies.
Welisson da Silva Ferreira (2008)
10.1016/J.JLUMIN.2017.08.007
Molecular interaction between human serum albumin (HSA) and phloroglucinol derivative that shows selective anti-proliferative potential
Moumita Mondal (2017)
10.1038/sj.onc.1206551
Human T-cell leukemia virus type I and adult T-cell leukemia
M. Matsuoka (2003)
10.1200/JOP.2017.021907
Adult T-Cell Leukemia/Lymphoma.
Neha Mehta-Shah (2017)
10.1007/s11899-018-0458-6
Adult T Cell Leukemia-Lymphoma (ATL): State of the Art
A. Phillips (2018)
10.1016/0042-6822(88)90232-2
Human immunodeficiency virus (HIV-1) cytotoxicity: perturbation of the cell membrane and depression of phospholipid synthesis.
W. S. Lynn (1988)
10.1016/j.cbi.2016.07.007
Impairment of oxidative phosphorylation increases the toxicity of SYD-1 on hepatocarcinoma cells (HepG2).
Anna Paula Brandt (2016)
10.1016/j.saa.2020.118410
Comprehensive investigations about the binding interaction of acesulfame with human serum albumin.
Hongmei Zhang (2020)
10.1016/j.jphotobiol.2015.10.023
Spectroscopic and molecular docking studies of binding interaction of gefitinib, lapatinib and sunitinib with bovine serum albumin (BSA).
Guofeng Shen (2015)
10.1016/j.bbagen.2013.05.005
Albumin-drug interaction and its clinical implication.
K. Yamasaki (2013)
10.1111/bjh.13338
Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study
T. Ishida (2015)
10.1186/s13167-015-0047-x
Analysis of aceclofenac and bovine serum albumin interaction using fluorescence quenching method for predictive, preventive, and personalized medicine
Sabiha Ferdowsy Koly (2015)
10.1021/JA0501159
Cytosine catalysis of nitrosative guanine deamination and interstrand cross-link formation.
R. Glaser (2005)
10.1016/j.jphotobiol.2018.10.006
Synthesis, theoretical, spectroscopic and electrochemical DNA binding investigations of 1, 3, 4-thiadiazole derivatives of ibuprofen and ciprofloxacin: Cancer cell line studies.
Shahid Iqbal Farooqi (2018)
10.1002/JHET.3489
New 1,3,4‐Thiadiazole Derivatives: Synthesis, Characterization, and Antimicrobial Activity
A. AboBakr (2019)
10.1097/00008390-200310000-00005
Effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on B16-F10 murine melanoma
A. Senff-Ribeiro (2003)
10.1016/j.ejmech.2012.06.011
Regioselective reaction: synthesis, characterization and pharmacological activity of some new Mannich and Schiff bases containing sydnone.
Nithinchandra (2012)
10.1080/00397910600941398
Synthesis of Mesoionic 4‐(para‐substituted Phenyl‐5‐2,4‐dichlorophenyl)‐1,3‐4‐thiadiazolium‐2‐aminides by Direct Cyclization via Acylation of Thiosemicarbazides
Marcelo Moreira Britto (2006)
10.1038/358209A0
Atomic structure and chemistry of human serum albumin
X. M. He (1992)
10.1016/S0167-4838(01)00151-0
Flunitrazepam, a 7-nitro-1,4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin.
V. Chuang (2001)
10.3390/molecules201019526
Fluorescence and Docking Studies of the Interaction between Human Serum Albumin and Pheophytin
O. Chaves (2015)
10.1080/073911012010525029
Probing the Interaction of Human Serum Albumin With Bilirubin in the Presence of Aspirin by Multi-Spectroscopic, Molecular Modeling and Zeta Potential Techniques: Insight on Binary and Ternary Systems
A. Hosainzadeh (2012)
10.1038/nrd4002
Modulation of oxidative stress as an anticancer strategy
C. Gorrini (2013)
10.1200/JCO.2008.18.2428
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.
K. Tsukasaki (2009)
10.1038/sj.bjp.0702076
Inhibitory effects of mesoionic 3‐aryl substituted oxatriazole‐5‐imine derivatives on vascular smooth muscle cell mitogenesis and proliferation in vitro
T. Lähteenmäki (1998)
10.1182/BLOOD.V50.3.481.BLOODJOURNAL503481
Adult T-cell leukemia: clinical and hematologic features of 16 cases
T. Uchiyama (1977)
10.1016/j.saa.2020.118289
Spectroscopy and molecular docking approach for investigation on the binding of nocodazole to human serum albumin.
I. Singh (2020)
10.1016/j.bmc.2019.115244
Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells.
Krishna Kumar Gnanasekaran (2019)
10.3390/molecules17066821
Binding of Bezafibrate to Human Serum Albumin: Insight into the Non-Covalent Interaction of an Emerging Contaminant with Biomacromolecules
Yajie Qian (2012)
10.1016/j.cytogfr.2011.08.002
Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
S. Olière (2011)
10.3390/molecules25020329
3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma
S. Cascioferro (2020)
10.2174/157340911795677602
Molecular docking: a powerful approach for structure-based drug discovery.
Xuan-Yu Meng (2011)
10.3389/fmicb.2012.00322
Adult T-Cell Leukemia: A Review of Epidemiological Evidence
M. Iwanaga (2012)
Further characterization of specific drug binding sites on human serum albumin.
G. Sudlow (1976)
10.1016/j.bmc.2020.115431
Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivatives.
Maria R Buemi (2020)
10.1016/J.MOLLIQ.2017.07.091
Spectroscopic, zeta potential and molecular docking analysis on the interaction between human serum albumin and halogenated thienyl chalcones
O. Chaves (2017)
10.3390/cancers7040893
Optimizing Management of Patients with Adult T Cell Leukemia-Lymphoma
Jean A Yared (2015)
10.1016/S0140-6736(08)60457-2
Acute lymphoblastic leukaemia
C. Pui (2008)
10.1002/jbt.20303
Metabolism of the mesoionic compound (MI‐D) by mouse liver microsome, detection of its metabolite In Vivo, and acute toxicity in mice
S. Romão (2009)
10.1128/CDLI.1.3.273-282.1994
Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production.
H. Prince (1994)
10.1016/S1470-2045(14)70202-5
Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.
K. Ishitsuka (2014)
10.1016/j.exppara.2013.05.008
In vitro evaluation of 4-phenyl-5-(4'-X-phenyl)-1,3,4-thiadiazolium-2-phenylaminide chlorides and 3[N-4'-X-phenyl]-1,2,3-oxadiazolium-5-olate derivatives on nitric oxide synthase and arginase activities of Leishmania amazonensis.
R. J. Soares-Bezerra (2013)
The characterization of two specific drug binding sites on human serum albumin.
G. Sudlow (1975)
10.1021/BI00514A017
Thermodynamics of protein association reactions: forces contributing to stability.
Philip D. Ross (1981)
10.3389/fmicb.2012.00388
Epidemiological Aspects and World Distribution of HTLV-1 Infection
A. Gessain (2012)
10.1016/S0040-4020(01)96625-6
Heterocyclic mesomeric betaines
W. Ollis (1985)
10.1016/S0959-440X(96)80030-3
Time-resolved fluorescence spectroscopy.
D. Millar (1996)
10.1016/j.cbi.2008.11.016
The inhibition of lipoperoxidation by mesoionic compound MI-D: a relationship with its uncoupling effect and scavenging activity.
S. Mendez-Sanchez (2009)
10.1021/JM00216A014
Synthesis and antileukemic activity of 5-substituted 2,3-dihydro-6,7-bis(hydroxymethyl)-1H-pyrrolizine diesters.
W. Anderson (1977)
10.1039/B705030E
The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.
E. Hillard (2007)
10.1073/PNAS.77.12.7415
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
B. Poiesz (1980)
10.1007/s11030-018-9851-2
Synthesis of new chiral 1,3,4-thiadiazole-based di- and tri-arylsulfonamide residues and evaluation of in vitro anti-HIV activity and cytotoxicity
Maria Shafique (2018)



Semantic Scholar Logo Some data provided by SemanticScholar